The Accelerated Access Collaborative
Executive Summary
- The Accelerated Access Collaborative (AAC) is the decision-making body for the Accelerated Access Pathway (AAP) which arose from the Government’s Accelerated Access Review (AAR)
- The Pathway provides a route and interim funding to enable widespread reimbursement of proven and cost-effective pharmaceuticals and medical devices
- Products selected for this route are expected to achieve a minimum of cost-neutrality, and ideally savings, a year after launch via the AAP
- Only licensed products (i.e. those with CE marking or marketing authorisation) are eligible for the scheme
Membership required to access MAP Online
Benefits of a membership to MAP Online include:
- Access to up-to-date, validated and detailed market access guides
- Downloadable tools, slide decks, flowcharts and more...
- Free workshops with every new membership to help you get the most out of MAP
MAP UK - Table of Contents